Can Illumina’s Bold Protein Analysis Strategy Reverse Its Market Slide?
Genomics leader Illumina finds itself navigating a complex strategic landscape. The company's latest quarterly results reveal continued revenue pressure, even ...
© 2024 Stocks Today